Flat corneas produce unpredictable visual outcomes after PRK

Article

Flat, steep corneas with keratometry values of less than 35 D do not have a predictive effect on the risk of visual acuity loss after myopic photorefractive keratectomy (PRK), claims a paper in the Journal of Refractive Surgery.

Flat, steep corneas with keratometry values of less than 35 D do not have a predictive effect on the risk of visual acuity loss after myopic photorefractive keratectomy (PRK), claims a paper in the Journal of Refractive Surgery.

Dr David Varssano et al., Tel-Aviv Medical Centre, Tel-Aviv, Israel, retrospectively analysed the visual acuity of 5410 eyes that underwent PRK from January 2006 to November 2010. All patients were assessed for the effect of postoperative corneal curvatures on visual outcomes. The main outcome measures were postoperative corrected distance visual acuity (CDVA) and loss of CDVA.

A worse postoperative CDVA was observed in corneas with a flat meridian of less than 35 D and those with a steep meridian of less than 35 D. The worst preoperative CDVA presented in the flatter curvatures in all comparisons conducted for the study. This indicates that calculated meridian curvature had no effect on CDVA loss.

Overall, the team discovered that postoperative corneal keratometry values, especially flat and steep meridians, of less than 35 D did not have a predictive effect on the risk of losing visual acuity after myopic PRK.

For the full abstract please click here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.